AXNX vs. IRTC, PRCT, HAE, MMSI, ICUI, IART, TNDM, NARI, ATEC, and LMAT
Should you be buying Axonics stock or one of its competitors? The main competitors of Axonics include iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Haemonetics (HAE), Merit Medical Systems (MMSI), ICU Medical (ICUI), Integra LifeSciences (IART), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Alphatec (ATEC), and LeMaitre Vascular (LMAT). These companies are all part of the "surgical & medical instruments" industry.
Axonics (NASDAQ:AXNX) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.
Axonics has higher earnings, but lower revenue than iRhythm Technologies. Axonics is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks.
In the previous week, Axonics had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for Axonics and 3 mentions for iRhythm Technologies. Axonics' average media sentiment score of 0.66 beat iRhythm Technologies' score of 0.28 indicating that Axonics is being referred to more favorably in the media.
iRhythm Technologies received 213 more outperform votes than Axonics when rated by MarketBeat users. However, 67.18% of users gave Axonics an outperform vote while only 65.93% of users gave iRhythm Technologies an outperform vote.
99.5% of Axonics shares are held by institutional investors. 1.9% of Axonics shares are held by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Axonics has a net margin of -1.66% compared to iRhythm Technologies' net margin of -25.05%. Axonics' return on equity of -1.00% beat iRhythm Technologies' return on equity.
Axonics presently has a consensus price target of $70.73, indicating a potential upside of 6.29%. iRhythm Technologies has a consensus price target of $135.11, indicating a potential upside of 21.43%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Axonics.
Axonics has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.
Summary
Axonics beats iRhythm Technologies on 11 of the 18 factors compared between the two stocks.
Get Axonics News Delivered to You Automatically
Sign up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AXNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
